These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 16574937

  • 1. Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses.
    Gauvreau GM, Hessel EM, Boulet LP, Coffman RL, O'Byrne PM.
    Am J Respir Crit Care Med; 2006 Jul 01; 174(1):15-20. PubMed ID: 16574937
    [Abstract] [Full Text] [Related]

  • 2. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice.
    Broide D, Schwarze J, Tighe H, Gifford T, Nguyen MD, Malek S, Van Uden J, Martin-Orozco E, Gelfand EW, Raz E.
    J Immunol; 1998 Dec 15; 161(12):7054-62. PubMed ID: 9862743
    [Abstract] [Full Text] [Related]

  • 3. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
    Swystun VA, Gordon JR, Davis EB, Zhang X, Cockcroft DW.
    J Allergy Clin Immunol; 2000 Jul 15; 106(1 Pt 1):57-64. PubMed ID: 10887306
    [Abstract] [Full Text] [Related]

  • 4. Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma.
    Diamant Z, Kuperus J, Baan R, Nietzmann K, Millet S, Mendes P, Miller B, Amin D, Rohatagi S, Sterk PJ, Hoogsteden HC, Prins JB.
    Clin Exp Allergy; 2005 Aug 15; 35(8):1080-7. PubMed ID: 16120091
    [Abstract] [Full Text] [Related]

  • 5. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
    Norris V, Choong L, Tran D, Corden Z, Boyce M, Arshad H, Holgate S, O'Connor B, Millet S, Miller B, Rohatagi S, Kirkesseli S.
    J Allergy Clin Immunol; 2005 Oct 15; 116(4):761-7. PubMed ID: 16210048
    [Abstract] [Full Text] [Related]

  • 6. Roflumilast, a phosphodiesterase 4 inhibitor, reduces airway hyperresponsiveness after allergen challenge.
    Louw C, Williams Z, Venter L, Leichtl S, Schmid-Wirlitsch C, Bredenbroker D, Bardin PG.
    Respiration; 2007 Oct 15; 74(4):411-7. PubMed ID: 16954654
    [Abstract] [Full Text] [Related]

  • 7. Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa.
    Fukakusa M, Bergeron C, Tulic MK, Fiset PO, Al Dewachi O, Laviolette M, Hamid Q, Chakir J.
    J Allergy Clin Immunol; 2005 Feb 15; 115(2):280-6. PubMed ID: 15696082
    [Abstract] [Full Text] [Related]

  • 8. Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction.
    Hessel EM, Chu M, Lizcano JO, Chang B, Herman N, Kell SA, Wills-Karp M, Coffman RL.
    J Exp Med; 2005 Dec 05; 202(11):1563-73. PubMed ID: 16314434
    [Abstract] [Full Text] [Related]

  • 9. Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti-IgE treatment.
    van Rensen EL, Evertse CE, van Schadewijk WA, van Wijngaarden S, Ayre G, Mauad T, Hiemstra PS, Sterk PJ, Rabe KF.
    Allergy; 2009 Jan 05; 64(1):72-80. PubMed ID: 19076931
    [Abstract] [Full Text] [Related]

  • 10. Effects of inhaled ciclesonide on circulating T-helper type 1/T-helper type 2 cells in atopic asthmatics after allergen challenge.
    Kawayama T, O'Byrne PM, Watson RM, Killian KJ, Duong M, Yoshida M, Gauvreau GM.
    Clin Exp Allergy; 2006 Nov 05; 36(11):1417-24. PubMed ID: 17083352
    [Abstract] [Full Text] [Related]

  • 11. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
    Flood-Page P, Swenson C, Faiferman I, Matthews J, Williams M, Brannick L, Robinson D, Wenzel S, Busse W, Hansel TT, Barnes NC, International Mepolizumab Study Group.
    Am J Respir Crit Care Med; 2007 Dec 01; 176(11):1062-71. PubMed ID: 17872493
    [Abstract] [Full Text] [Related]

  • 12. Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses.
    Gauvreau GM, Boulet LP, Cockcroft DW, Baatjes A, Cote J, Deschesnes F, Davis B, Strinich T, Howie K, Duong M, Watson RM, Renzi PM, O'Byrne PM.
    Am J Respir Crit Care Med; 2008 May 01; 177(9):952-8. PubMed ID: 18244953
    [Abstract] [Full Text] [Related]

  • 13. Effect of an NK1/NK2 receptor antagonist on airway responses and inflammation to allergen in asthma.
    Boot JD, de Haas S, Tarasevych S, Roy C, Wang L, Amin D, Cohen J, Sterk PJ, Miller B, Paccaly A, Burggraaf J, Cohen AF, Diamant Z.
    Am J Respir Crit Care Med; 2007 Mar 01; 175(5):450-7. PubMed ID: 17170385
    [Abstract] [Full Text] [Related]

  • 14. Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy.
    Subbarao P, Dorman SC, Rerecich T, Watson RM, Gauvreau GM, O'Byrne PM.
    J Allergy Clin Immunol; 2005 Apr 01; 115(4):745-50. PubMed ID: 15805993
    [Abstract] [Full Text] [Related]

  • 15. The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma.
    Ravensberg AJ, Luijk B, Westers P, Hiemstra PS, Sterk PJ, Lammers JW, Rabe KF.
    Allergy; 2006 Sep 01; 61(9):1097-103. PubMed ID: 16918513
    [Abstract] [Full Text] [Related]

  • 16. Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma.
    Boulet LP, Turcotte H, Prince P, Lemière C, Olivenstein R, Laprise C, Larivée P, Bégin P, Laviolette M.
    Respir Med; 2009 Oct 01; 103(10):1554-63. PubMed ID: 19692221
    [Abstract] [Full Text] [Related]

  • 17. Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma.
    Gauvreau GM, Boulet LP, Cockcroft DW, Fitzgerald JM, Carlsten C, Davis BE, Deschesnes F, Duong M, Durn BL, Howie KJ, Hui L, Kasaian MT, Killian KJ, Strinich TX, Watson RM, Y N, Zhou S, Raible D, O'Byrne PM.
    Am J Respir Crit Care Med; 2011 Apr 15; 183(8):1007-14. PubMed ID: 21057005
    [Abstract] [Full Text] [Related]

  • 18. Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge.
    Schubert R, Kitz R, Beermann C, Rose MA, Lieb A, Sommerer PC, Moskovits J, Alberternst H, Böhles HJ, Schulze J, Zielen S.
    Int Arch Allergy Immunol; 2009 Apr 15; 148(4):321-9. PubMed ID: 19001792
    [Abstract] [Full Text] [Related]

  • 19. Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects.
    Liu MC, Proud D, Lichtenstein LM, Hubbard WC, Bochner BS, Stealey BA, Breslin L, Xiao H, Freidhoff LR, Schroeder JT, Schleimer RP.
    J Allergy Clin Immunol; 2001 Jul 15; 108(1):29-38. PubMed ID: 11447379
    [Abstract] [Full Text] [Related]

  • 20. Effect of low-dose ciclesonide on allergen-induced responses in subjects with mild allergic asthma.
    Gauvreau GM, Boulet LP, Postma DS, Kawayama T, Watson RM, Duong M, Deschesnes F, De Monchy JG, O'Byrne PM.
    J Allergy Clin Immunol; 2005 Aug 15; 116(2):285-91. PubMed ID: 16083781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.